Allison Curtis Kingsley Meoz Michael & Sanchez PC

Allison Curtis Kingsley Meoz Michael & Sanchez PC was paid $13.46M by Medicaid between Jan 2018 and Dec 2024, across 92 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.

33Billing provider infoALLISON CURTIS KINGSLEY MEOZ MICHAEL & SANCHEZ PC
LAS VEGAS, NV 89169

33aNPI1598770471assigned 07/29/2006

33bProvider typePulmonary Disease Physician

28Total paid$13.46M

24GClaims483,618

24DCodes billed92

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Pulmonary Disease Physician providers in Nevada

Rank by total paid#2 of 22

Median peer was paid$82K

This provider vs. median164×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	26,704	$394K
2019	82,027	$2.05M
2020	85,593	$2.63M
2021	92,145	$3.01M
2022	78,255	$2.11M
2023	77,867	$2.23M
2024incomplete	41,027	$1.03M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	29%	62,132	51,444	$3.86M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	13%	22,896	13,862	$1.74M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	12%	36,118	32,047	$1.63M
99232	Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity	4.8%	24,538	7,040	$647K
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	4.0%	1,975	475	$542K
96375	Therapeutic injection; each additional sequential IV push	3.9%	33,139	19,150	$529K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	3.2%	690	422	$430K
J2469	Injection, palonosetron hcl, 25 mcg	3.0%	5,633	3,022	$407K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	2.9%	5,493	4,184	$385K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	2.3%	7,968	4,981	$316K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	2.3%	2,523	2,409	$309K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	1.9%	167	63	$262K

80 more codes

J1453	Injection, fosaprepitant, 1 mg	1.8%	3,037	$248K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.8%	77,117	$247K
80053	Comprehensive metabolic panel	1.5%	49,752	$207K
99233	Hospital visit by a doctor, follow-up day (complex)	1.3%	2,936	$175K
99223	Prolong inpt eval add15 m	1.2%	1,457	$158K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.1%	13,730	$151K
77014		1.1%	1,654	$142K
77427		<1%	908	$99K
96367		<1%	4,800	$88K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	95	$85K
96417		<1%	2,207	$85K
96416		<1%	667	$68K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	1,838	$63K
82728		<1%	9,295	$55K
82378		<1%	4,672	$39K
J0185	Injection, aprepitant, 1 mg	<1%	219	$36K
J9190	Injection, fluorouracil, 500 mg	<1%	1,591	$32K
83615		<1%	12,212	$30K
36415	Collection of venous blood by venipuncture	<1%	34,362	$25K
83550		<1%	6,843	$23K
76641		<1%	279	$23K
J1750	Injection, iron dextran, 50 mg	<1%	205	$23K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	21,305	$21K
99222	Initial hospital care, per day, moderate complexity	<1%	407	$20K
83540		<1%	7,431	$20K
94060		<1%	558	$18K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	236	$18K
86300		<1%	1,834	$18K
96415		<1%	781	$18K
77336		<1%	365	$17K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	1,398	$17K
J3490	Unclassified drugs	<1%	606	$15K
Q5101	Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram	<1%	63	$13K
99205	Prolong outpt/office vis	<1%	91	$13K
82607		<1%	1,975	$13K
J1756	Injection, iron sucrose, 1 mg	<1%	155	$10K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	261	$10K
94729		<1%	216	$7K
96361	Intravenous infusion, hydration; each additional hour	<1%	431	$5K
94375		<1%	259	$5K
82746		<1%	663	$4K
96411		<1%	115	$4K
84443	Thyroid stimulating hormone (TSH)	<1%	617	$4K
96521		<1%	43	$3K
99203	Doctor's office visit, new patient (routine)	<1%	48	$3K
94726		<1%	79	$3K
84439		<1%	726	$3K
80048	Basic metabolic panel (calcium, ionized)	<1%	639	$2K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	4,328	$2K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	91	$2K
80050	General health panel	<1%	70	$2K
J1626	Injection, granisetron hydrochloride, 100 mcg	<1%	548	$1K
80076		<1%	398	$1K
84436		<1%	414	$1K
85652		<1%	964	$1K
J9206	Injection, irinotecan, 20 mg	<1%	45	$939.76
94664		<1%	99	$885.05
96368		<1%	85	$853.75
84153		<1%	341	$722.48
94618		<1%	29	$557.48
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	42	$524.95
84481		<1%	42	$441.48
90674		<1%	27	$422.63
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	14	$419.48
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	268	$293.81
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	973	$252.24
90686		<1%	24	$212.34
82784		<1%	32	$135.51
86334		<1%	15	$128.16
J7030	Infusion, normal saline solution , 1000 cc	<1%	82	$116.20
82232		<1%	13	$77.88
84165		<1%	15	$61.59
J2270	Injection, morphine sulfate, up to 10 mg	<1%	95	$54.40
J0461	Injection, atropine sulfate, 0.01 mg	<1%	34	$42.54
85045		<1%	12	$30.78
82565		<1%	12	$28.25
84520		<1%	12	$24.37
85018		<1%	14	$14.64
G0008	Administration of influenza virus vaccine	<1%	17	$2.89
G1007	Clinical decision support mechanism aim specialty health, as defined by the medicare appropriate use criteria program	0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPARIKH, RUPESH (PRACTICE PRESIDENT)